Arbor Pharmaceuticals recalls
Arbor Pharmaceuticals has 3 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 7 Oct 2020. The most frequent reason is packaging defects.
Total recalls3since 2016
Last 12 months0reported
Class I133% of total
Ongoing0latest 7 Oct 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 33%Class II 0 0%Class III 2 67%
Why arbor pharmaceuticals is recalled
Product types
By year
All arbor pharmaceuticals recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Nymalize (nimodipine) oral solution, 60 mg/-Dose Cups recalled | Arbor Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Testosterone Cypionate Injection, USP, 2000 mg/ Vial, Single-Dose recalledTestosterone Cypionate | Arbor Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS I | Cetylev (acetylcysteine) effervescent tablets recalled | Arbor Pharmaceuticals | Packaging Defects | 14 states |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.